Nu Skin Enterprises, Inc. (NUS) Given New $57.00 Price Target at Bank of America Corporation
Nu Skin Enterprises, Inc. (NYSE:NUS) had its price objective boosted by stock analysts at Bank of America Corporation from $53.00 to $57.00 in a note issued to investors on Monday. The brokerage currently has an “underperform” rating on the stock. Bank of America Corporation’s price target indicates a potential downside of 9.05% from the stock’s previous close.
Other analysts have also recently issued research reports about the stock. Zacks Investment Research cut shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research report on Saturday, June 24th. Deutsche Bank AG raised their price objective on shares of Nu Skin Enterprises from $63.00 to $66.00 and gave the company a “buy” rating in a research report on Wednesday, June 21st. Sidoti cut shares of Nu Skin Enterprises from a “buy” rating to a “neutral” rating and set a $59.00 price objective on the stock. in a research report on Wednesday, April 26th. Pivotal Research restated a “buy” rating and set a $65.00 price objective on shares of Nu Skin Enterprises in a research report on Thursday, May 4th. Finally, ValuEngine upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $61.38.
Nu Skin Enterprises (NYSE:NUS) traded up 0.84% on Monday, hitting $62.67. The stock had a trading volume of 424,138 shares. Nu Skin Enterprises has a 12-month low of $45.00 and a 12-month high of $66.04. The company has a market capitalization of $3.31 billion, a PE ratio of 20.80 and a beta of 1.32. The company has a 50 day moving average of $58.20 and a 200 day moving average of $53.72.
Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings data on Wednesday, May 3rd. The company reported $0.51 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.50 by $0.01. The firm had revenue of $499.10 million for the quarter, compared to analysts’ expectations of $493.65 million. Nu Skin Enterprises had a net margin of 7.48% and a return on equity of 23.45%. The business’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter last year, the company posted $0.42 EPS. On average, equities analysts expect that Nu Skin Enterprises will post $3.12 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 14th. Investors of record on Friday, May 26th were given a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 2.30%. The ex-dividend date was Wednesday, May 24th. Nu Skin Enterprises’s payout ratio is presently 48.48%.
In related news, General Counsel D Matthew Dorny sold 8,000 shares of Nu Skin Enterprises stock in a transaction on Monday, June 5th. The shares were sold at an average price of $56.39, for a total value of $451,120.00. Following the transaction, the general counsel now owns 52,730 shares in the company, valued at approximately $2,973,444.70. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In the last quarter, insiders sold 24,250 shares of company stock worth $1,436,770. 5.20% of the stock is owned by corporate insiders.
A number of institutional investors have recently modified their holdings of the company. Russell Investments Group Ltd. purchased a new position in Nu Skin Enterprises during the fourth quarter worth about $3,124,000. State Street Corp boosted its position in Nu Skin Enterprises by 2.4% in the fourth quarter. State Street Corp now owns 802,056 shares of the company’s stock worth $38,321,000 after buying an additional 18,471 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in Nu Skin Enterprises by 4.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 947,226 shares of the company’s stock worth $45,260,000 after buying an additional 39,926 shares during the last quarter. Renaissance Technologies LLC boosted its position in Nu Skin Enterprises by 269.9% in the fourth quarter. Renaissance Technologies LLC now owns 200,100 shares of the company’s stock worth $9,561,000 after buying an additional 146,000 shares during the last quarter. Finally, New York State Teachers Retirement System boosted its position in Nu Skin Enterprises by 2.1% in the fourth quarter. New York State Teachers Retirement System now owns 4,900 shares of the company’s stock worth $234,000 after buying an additional 100 shares during the last quarter. Institutional investors own 85.54% of the company’s stock.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.